Neisseria meningitidis: Pathogenetic mechanisms to overcome the human immune defences

Journal of Preventive Medicine and Hygiene

Volumn 53, Issue 2, 2012, Pages 50-55

  Gasparini, R ^a   Amicizia, D ^a   Lai, P L ^a   Panatto, D ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Immune system; Neisseria meningitidis; Pathogenetic factors; Vaccines; Virulence

Indexed keywords

ADHESIN; BACTERIAL ANTIGEN; FICOLIN; HEPARIN; INTEGRIN; LIPOPOLYSACCHARIDE; MANNAN BINDING LECTIN; NEISSERIAL ADHESIN A; NEISSERIAL HEPARIN BINDING ANTIGEN; PILIN; PORIN A; UNCLASSIFIED DRUG; VITRONECTIN;

BACTERIAL COLONIZATION; BACTERIAL MEMBRANE; BACTERIAL OUTER MEMBRANE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CELL ADHESION; CELL INVASION; CELL MATURATION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DENDRITIC CELL; HOST RESISTANCE; HUMAN; LEPTOMENINX; MACROPHAGE; MUCOSA CELL; NASOPHARYNX; NEISSERIA MENINGITIDIS; NEUTROPHIL; NONHUMAN; NOSE MUCOSA; PHAGOCYTE; PROTEIN EXPRESSION; RESPIRATORY TRACT MUCOSA; REVIEW;

BACTERIAL PROTEINS; CARRIER STATE; HUMANS; NASOPHARYNX; NEISSERIA MENINGITIDIS; NEISSERIACEAE INFECTIONS;

EID: 84864687895     PISSN: 11212233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. De Filippis I. Quest for a broad-range vaccine against Neisseria meningitidis serogroup B: implications of genetic variations of the surface-exposed proteins. J Med Microbiol 2009;58(Pt 9):1127-32.
2. Ron EZ. Editorial: An update on bacterial stress response. Res Microbiol 2009;160:243-4.
3. Lo H, Tang CM, Exley RM. Mechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine development. Lancet Infect Dis 2009;9:418-27.
4. Guzzetta G, Manfredi P, Gasparini R, et al. On the relationship between meningococcal transmission dynamics and disease: remarks on humoral immunity. Vaccine 2009;27:3429-34.
5. Gasparini R, Rizzetto R, Sasso T, et al. Seroprevalence of bactericidal antibody against Neisseria meningitidis serogroup C in pre-vaccinal era: the Italian epidemiological scenario. Vaccine. 2009;26:27:3435-8.
6. Soriano-Gabarrò M, Wolter J, Hogea C, et al. Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region. Expert Rev Anti Infect Ther 2011;9:761-74.
7. Tettelin H, Saunders NJ, Heidelberg J, et al. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 2000;287:1809-15. (Pubitemid 30143964)
8. Hill DJ, Griffiths NJ, Borodina E, et al. Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease. Clin Sci (Lond) 2010;118:547-64.
9. Craig L, Volkmann N, Arvai AS, et al. Type IV pilus structure by cryo-electron microscopy and crystallography: implications for pilus assembly and functions. Mol Cell 2006;23:651-62. (Pubitemid 44292553)
10. Kirchner M, Meyer TF. The PilC adhesin of the Neisseria type IV pilus-binding specificities and new insights into the nature of the host cell receptor. Mol Microbiol 2005;56:945-57. (Pubitemid 40646767)
11. Orihuela CJ, Mahdavi J, Thornton J, et al. Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models. J Clin Invest 2009;119:1638-46.
12. Virji M, Makepeace K, Ferguson DJ, et al. Carcinoembryonic antigens (CD66) on epithelial cells and neutrophils are receptors for Opa proteins of pathogenic neisseriae. Mol Microbiol 1996;22:941-50. (Pubitemid 26411338)
13. Virji M, Watt SM, Barker S, et al. The N-domain of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae. Mol Microbiol 1996;22:929-39. (Pubitemid 26411337)
14. Virji M, Evans D, Hadfield A, et al. Critical determinants of host receptor targeting by Neisseria meningitidis and Neisseria gonorrhoeae: identification of Opa adhesiotopes on the Ndomain of CD66 molecules. Mol Microbiol 1999;34:538-51. (Pubitemid 29507314)
15. Cunha CS, Griffiths NJ, Murillo I, et al. Neisseria meningitidis Opc invasin binds to the cytoskeletal protein α-actinin. Cell Microbiol 2009;11:389-405.
16. Novak N, Bieber T. 2: Dendritic cells as regulators of immunity and tolerance. J Allergy Clin Immunol 2008;121(2 suppl):S370-74. (Pubitemid 351172419)
17. Kolb-Maurer A, Unkmeir A, Kammerer U, et al. Interaction of Neisseria meningitidis with human dendritic cells. Infect Immun 2001;69:6912-22. (Pubitemid 32995451)
18. Unkmeir A, Kammerer U, Stade A, et al. Lipooligosaccharide and polysaccharide capsule: virulence factors of Neisseria meningitides that determine meningococcal interaction with human dendritic cells. Infect Immun 2002;70:2454-62. (Pubitemid 34408387)
19. Kurzai O, Schmitt C, Claus H, et al. Carbohydrate composition of meningococcal lipopolysaccharide modulates the interaction of Neisseria meningitidis with human dendritic cells. Cell Microbiol 2005;7:1319-34. (Pubitemid 41179424)
20. Jones HE, Uronen-Hansson H, Callard RE, et al. The differential response of human dendritic cells to live and killed Neisseria meningitidis. Cell Microbiol 2007;9:2856-69. (Pubitemid 350066570)
21. Borregaard N, Sorensen OE, Theilgaard-Monch K. Neutrophil granules: a library of innate immunity proteins. Trends Immunol 2007;28:340-5. (Pubitemid 47077924)
22. Pangburn MK, Ferreira V, Cortes C. Discrimination between host and pathogens by the complement system. Vaccine 2008;26S:I15-I21.
23. Xu W, Berger SP, Trouw LA, et al. Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation. J Immunol 2008;180:7613-21.
24. Thiel S. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins. Mol Immunol 2007;44:3875-88. (Pubitemid 47337117)
25. Panatto D, Amicizia D, Lai PL, et al. Neisseria meningitidis B vaccines. Expert Rev Vaccines. 2011;10:1337-51.
26. Schneider MC, Exely RM, Ram S, et al. Interactions between Neisseria meningitidis and the complement system. Trends Microbiol 2007;15:233-40. (Pubitemid 46671509)
27. Geoffroy MC, Floquet S, Metais A, et al. Large-scale analysis of the meningococcus genome by gene disruption: resistance to complement-mediated lysis. Genome Res 2003;13:391-8. (Pubitemid 36395396)
28. Welsch JA, Ram S. Factor H and Neisserial pathogenesis. Vaccine 2008;26(Suppl 8):I40-145.
29. Lewis LA, Ngampasutadol J, Wallace R, et al. The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement. PLoS Pathog 2010.6(7),e1001027 (2010).
30. Serruto D, Spadafina T, Ciucchi L, et al. Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans. Proc Natl Acad Sci USA 2010;107:3770-5.
31. Swartley JS, Liu LJ, Miller YK, et al. Characterization of the gene cassette required for biosynthesis of the (α1→6)-linked N-acetyl-d-mannosamine-1-phosphate capsule of serogroup A Neisseria meningitidis. J. Bacteriol 1998;180:1533-9. (Pubitemid 28125739)
32. Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 2007;369:2196-210. (Pubitemid 46977462)
33. Unkmeir, A., Latsch, K, Dietrich G, et al. Fibronectin mediates Opc-dependent internalization of Neisseria meningitidis in human brain microvascular endothelial cells. Mol Microbiol 2002;46:933-46. (Pubitemid 35370583)
34. Carbonnelle E, Hill DJ, Morand P, et al. Meningococcal interactions with the host. Vaccine 2009;27(Suppl. 2): B78-B89.
35. Dunn KL, Virji M, Moxon ER. Investigations into the molecular basis of meningococcal toxicity for human endothelial and epithelial cells: the synergistic effect of LPS and pili. Microb Pathog 1995;18:81-96.
36. Fowler MI, Yin KY, Humphries HE, et al. Comparison of the inflammatory responses of human meningeal cells following challenge with Neisseria lactamica and with Neisseria meningitidis. Infect Immun 2006;74:6467-78. (Pubitemid 44657429)